1 Min Read
Oct 17 (Reuters) - Depomed Inc said activist investor Starboard Value LP, which owns 9.8 percent of the drugmaker, had dropped its bid to oust the company's board.
The company said a special shareholder meeting scheduled for Nov. 15 was canceled.
Depomed, which has six directors on its board, said Starboard would appoint three independent directors - James Fogarty, Robert Savage and James Tyree. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel)